Literature DB >> 18213696

Indeterminate colitis: a review of the concept--what's in a name?

Karel Geboes1, Jean-Frédéric Colombel, Adrian Greenstein, Derek P Jewell, William J Sandborn, Morten H Vatn, Bryan Warren, Robert H Riddell.   

Abstract

The precise diagnosis of colitis cannot always be established with the available diagnostic tools. The subgroup of patients with an uncertain diagnosis has been classified as "indeterminate colitis" (IC). The definition of "indeterminate," however, has changed over the years. Originally, IC was proposed by pathologists for colectomy specimens, usually from patients operated on for severe colitis, showing overlapping features of ulcerative colitis (UC) and Crohn's disease (CD). Later, the same terminology was used for patients showing no clear clinical, endoscopic, histologic, and other features allowing a diagnosis of either UC or CD. Therefore, it is difficult to compare different studies. An International Organization of Inflammatory Bowel Diseases (IOIBD) working party confirmed 1) the ambiguous nature of the term, and 2) proposes an updated classification for the category of patients with an unclear diagnosis. According to this, the term IBD unclassified (IBDU) is confirmed, as suggested by the Montreal Working Party 2005 for patients with clinically chronic colitis, that clearly have IBD but when definitive features of CD or UC are absent. In resected specimens the term "colitis of uncertain type or etiology" (CUTE) is preferred. It is accepted that most of the time this may have a prefix, such as severe, chronic. The classification of IBD varies when based only on biopsies rather than on a colectomy specimen. The vast majority of these have severe colitis. For those that cannot bear to abandon the highly ambiguous term IC, if it is used at all, this is where it can be used parenthetically.

Entities:  

Mesh:

Year:  2008        PMID: 18213696     DOI: 10.1002/ibd.20361

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  33 in total

1.  Diagnosis and treatment of indeterminate colitis.

Authors:  William J Tremaine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

Review 2.  Is indeterminate colitis determinable?

Authors:  William J Tremaine
Journal:  Curr Gastroenterol Rep       Date:  2012-04

3.  Focally enhanced gastritis in newly diagnosed pediatric inflammatory bowel disease.

Authors:  Tetsuo Ushiku; Christopher J Moran; Gregory Y Lauwers
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

4.  Crohn's colitis complicated by cytomegalovirus infection.

Authors:  Barrett G Levesque; Reetesh Pai; Christine A Cartwright
Journal:  Dig Dis Sci       Date:  2009-07-03       Impact factor: 3.199

Review 5.  Natural history and complications of IBD.

Authors:  Morten H Vatn
Journal:  Curr Gastroenterol Rep       Date:  2009-12

6.  Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.

Authors:  Maria Teresa Arias-Loste; Geovana Bonilla; Irene Moraleja; Michael Mahler; Miguel Angel Mieses; Beatriz Castro; Montserrat Rivero; Javier Crespo; Marcos López-Hoyos
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

7.  Evaluation of diagnostic criteria for Crohn's disease in Japan.

Authors:  Takashi Hisabe; Fumihito Hirai; Toshiyuki Matsui; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2013-04-03       Impact factor: 7.527

8.  Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse.

Authors:  Jun Shen; Yuqi Qiao; Zhihua Ran; Tianrong Wang; Jiangtao Xu; Jinsun Feng
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

9.  High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.

Authors:  Steven Shamah; Judy Schneider; Burton I Korelitz
Journal:  Dig Dis Sci       Date:  2017-12-28       Impact factor: 3.199

Review 10.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.